Skip to content

Author

Allan D. Kirk

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Regulatory T cell modulation with selective CD28 blockade and IL-6 receptor antagonist in kidney transplant recipients: results of CTOT-24, a prospective clinical trial.

It is concluded that a regimen of combined CD28 and IL-6 blockade prevented rejection in only a minority and that alternative strategies are needed to promote Tregs under CD28 blockade.

S. Chandran, Qi-Zhi Tang, Joey C. Leung et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.